• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Abeona Therapeutics Inc. - Common Stock (NQ:ABEO)

    4.525 -0.025 (-0.55%)
    Streaming Delayed Price Updated: 1:33 PM EDT, Mar 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 512,477
    Open 4.500
    Bid (Size) 4.520 (600)
    Ask (Size) 4.530 (1,300)
    Prev. Close 4.550
    Today's Range 4.470 - 4.575
    52wk Range 3.933 - 7.540
    Shares Outstanding 54,191,361
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Abeona (ABEO) Q4 2025 Earnings Call Transcript ↗
    Abeona (ABEO) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    Abeona Therapeutics (NASDAQ:ABEO) Reports First Commercial Revenue and Bolstered Balance Sheet in 2025 ↗
    Via Chartmill

    Performance

    YTD
    -14.8%
    -14.8%
    1 Month
    -10.2%
    -10.2%
    3 Month
    -6.7%
    -6.7%
    6 Month
    -19.8%
    -19.8%
    1 Year
    -12.3%
    -12.3%

    More News

    Read More
    News headline image
    Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 12, 2025 ↗
    Via Benzinga
    News headline image
    Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Here's Why Abeona Therapeutics Popped Higher Today ↗
    Via The Motley Fool
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Abeona Therapeutics (NASDAQ:ABEO) Stock Falls on Revenue Miss Despite Q3 EPS Beat ↗
    Via Chartmill
    News headline image
    Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    What to Expect from Abeona Therapeutics's Earnings ↗
    Via Benzinga
    News headline image
    Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
    From Abeona Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
    From Abeona Therapeutics Inc.; Children's Hospital of Colorado
    Via GlobeNewswire

    Frequently Asked Questions

    Is Abeona Therapeutics Inc. - Common Stock publicly traded?
    Yes, Abeona Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Abeona Therapeutics Inc. - Common Stock trade on?
    Abeona Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Abeona Therapeutics Inc. - Common Stock?
    The ticker symbol for Abeona Therapeutics Inc. - Common Stock is ABEO on the Nasdaq Stock Market
    What is the current price of Abeona Therapeutics Inc. - Common Stock?
    The current price of Abeona Therapeutics Inc. - Common Stock is 4.525
    When was Abeona Therapeutics Inc. - Common Stock last traded?
    The last trade of Abeona Therapeutics Inc. - Common Stock was at 03/19/26 01:33 PM ET
    What is the market capitalization of Abeona Therapeutics Inc. - Common Stock?
    The market capitalization of Abeona Therapeutics Inc. - Common Stock is 245.22M
    How many shares of Abeona Therapeutics Inc. - Common Stock are outstanding?
    Abeona Therapeutics Inc. - Common Stock has 245M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.